Doctor profile · Federal record
Dr. Mark Robertshaw
Pulmonary Disease Physician (CMS: Internal Medicine) · Critical Care Medicine (Internal Medicine) Physician · Plano, TX
- NPI 1396277265
- Accepts Medicare
- 9 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6124 W Parker RD, Professional Office Building 3, Suite 530
Plano, TX 750938122
(214) 778-1075
Credentials & registration
- NPI registered
- March 2017 — 9 yrs on file
- Profile last updated
- October 1, 2024
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Texas #S6924
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1396277265. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
281
Distinct HCPCS
4
Medicare allowed
$32,507
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 140 | 72 | $76 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 67 | 38 | $114 | |
99291 |
Critical care, first 30-74 minutes | 49 | 27 | $205 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 25 | 24 | $167 |
In context: peer comparison
Among 5 peers in Plano Pulmonary Disease Physician, average services per provider: 120. This provider delivers 2.3× the peer median.Open Payments
Industry payments received
All-time total
$372
Transactions
13
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genzyme Corporation | 1 | $121.82 | |
| Insmed, INC. | 2 | $35.37 | |
| GlaxoSmithKline, LLC. | 2 | $33.53 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $29.58 | |
| United Therapeutics Corporation | 1 | $27.84 | |
| Gilead Sciences, INC. | 1 | $26.23 | |
| Grifols USA, LLC | 1 | $24.86 | |
| Abbvie INC. | 1 | $21.88 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $21.04 | |
| Baxter Healthcare | 1 | $15.75 | |
| Philips North America LLC | 1 | $14.10 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
63
Patients
0
Total drug cost
$10,413
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 24 | 0 | $866 |
| Advair Diskus (Fluticasone Propion/Salmeterol) | Brand | 23 | 0 | $9,327 |
| Furosemide | Generic | 16 | 0 | $220 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Robertshaw's medical specialty?
Dr. Mark Robertshaw practices Pulmonary Disease Physician in Plano, TX.
Where does Dr. Mark Robertshaw practice?
Dr. Mark Robertshaw practices at 6124 W Parker RD, Plano, TX 750938122. Office phone: 2147781075.
What is Dr. Mark Robertshaw's NPI?
Dr. Mark Robertshaw's National Provider Identifier (NPI) is 1396277265, issued by NPPES.
Does Dr. Mark Robertshaw accept Medicare assignment?
Yes. Dr. Mark Robertshaw accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Robertshaw commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Critical care (HCPCS 99291). Source: CMS Medicare Physician & Other Practitioners file.